Effects of highly active antiretroviral therapy initiation on epigenomic DNA methylation in persons living with HIV

By sjmartinez • June 10, 2024

Zhang J, Sehl ME, Shih R, Breen EC, Li F, Lu AT, Bream JH, Duggal P, Martinson J, Wolinsky SM, Martinez-Maza O, Ramirez CM, Horvath S, Jamieson BD. Effects of highly active antiretroviral therapy initiation on epigenomic DNA methylation in persons living with HIV. Front Bioinform. 2024 May 24;4:1357889. doi: 10.3389/fbinf.2024.1357889. PMID: 38855142; PMCID: PMC11157437.

Tags: antiretroviral therapy, bioinformatics, DNA methylation, epigenetics, EWAS, Hematology/Oncology, HIV, Publications

Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial

Bandos H, Kim S, Henry NL, Hays RD, Calsavara VF, Luu M, Gresham G, Lu KY, Irvin WJ, Suga JM, Siddique S, Cecchini RS, Rogatko[...]

CD19 Expression in B-Cell Lymphomas and Clinical Considerations in the Evolving Landscape of CD19-Targeted Therapy

Marshalek JP, Qing X, Tomassetti S. CD19 Expression in B-Cell Lymphomas and Clinical Considerations in the Evolving Landscape of CD19-Targeted Therapy. World J Oncol. 2025[...]

Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinoma

Hecht JR, Oberoi A, Garralda Cabanas E, Jae Chon H, Digklia A, Rottey S, Martin Jimenez M, Chaney M, Hippenmeyer J, Lawrence T, Liu K,[...]